Susquehanna International Group
TPST icon

Susquehanna International Group’s Tempest Therapeutics TPST Stock Holding History

Susquehanna International Group’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,077
Closed -$10.4K – 13731
2025
Q1 		$10.4K Buy
+1,077
New +$12.2K ﹤0.01% 12211
2024
Q4 		– Sell
-1,308
Closed -$23.8K – 13236
2024
Q3 		$23.8K Buy
+1,308
New +$26.8K ﹤0.01% 11591
2024
Q2 		– Sell
-11,285
Closed -$574K – 13249
2024
Q1 		$574K Buy
11,285
+8,216
+268% +$415K ﹤0.01% 8179
2023
Q4 		$176K Buy
+3,069
New +$145K ﹤0.01% 10817
2020
Q4 		– Sell
-144
Closed -$46K – 11746
2020
Q3 		$46K Buy
144
+73
+103% +$24.8K ﹤0.01% 10222
2020
Q2 		$24K Sell
71
-146
-67% -$58.2K ﹤0.01% 9899
2020
Q1 		$224K Buy
+217
New +$316K ﹤0.01% 8489
2016
Q1 		– Sell
-45
Closed -$1.3M – 9676
2015
Q4 		$1.3M Sell
45
-11
-20% -$363K ﹤0.01% 4890
2015
Q3 		$1.39M Buy
56
+31
+124% +$2.09M ﹤0.01% 5027
2015
Q2 		$2.08M Buy
25
+23
+1,150% +$2.11M ﹤0.01% 4630
2015
Q1 		$212K Buy
+2
New +$266K ﹤0.01% 8556

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's TPST Position: Q2 2025 in Review

Susquehanna International Group sold out of Tempest Therapeutics (TPST) in Q2 2025, closing a stake of 8,812 shares — an estimated $62.6K sold.

Susquehanna International Group first reported a position in TPST in Q2 2013 and held it in 21 quarters. The position peaked at $3.1M in Q2 2015. 18 funds tracked by Wall St. Rank hold TPST as of Q2 2025.

  • Susquehanna International Group reported no remaining Tempest Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 8,812 Tempest Therapeutics shares in Q2 2025, an estimated $62.6K.
  • Susquehanna International Group first reported a position in Tempest Therapeutics in Q2 2013 and held it in 21 quarters.
  • Susquehanna International Group's Tempest Therapeutics position peaked at $3.1M in Q2 2015.
  • 18 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.